These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 100214)

  • 1. Regulatory interrelationships for insulin and estrogen action in mammary tumors.
    Hilf R; Hissin PJ; Shafie SM
    Cancer Res; 1978 Nov; 38(11 Pt 2):4076-85. PubMed ID: 100214
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of insulin and estrogen on hormone binding in the R3230AC mammary adenocarcinoma.
    Shafie SM; Gibson SL; Hilf R
    Cancer Res; 1977 Dec; 37(12):4641-9. PubMed ID: 922744
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of estrogen to alter amino acid transport in R3230AC mammary carcinomas and its relationship to insulin action.
    Hissin PJ; Hilf R
    Cancer Res; 1979 Sep; 39(9):3381-7. PubMed ID: 157804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Shafie SM; Hilf R
    Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiestrogen modulation of the growth and properties of ovarian-autonomous and ovarian-dependent mammary tumors in rats.
    Tsai TL; Rutledge S; Katzenellenbogen BS
    Cancer Res; 1979 Dec; 39(12):5043-50. PubMed ID: 227594
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oophorectomy on estrogen receptors in rat mammary tumors induced by 7,12-dimethylbenz (a)anthracene.
    Tominaga T; Kitamura M; Tei N
    Biken J; 1977 Dec; 20(3-4):143-5. PubMed ID: 96813
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin receptor levels and magnitude of insulin-induced responses in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Shafie SM; Hilf R
    Cancer Res; 1981 Mar; 41(3):826-9. PubMed ID: 6780189
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.
    Cho-Chung YS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of insulin in vivo and in vitro on amino acid transport into cells from the R3230AC mammary adenocarcinoma and their relationship to tumor growth.
    Hissin PJ; Hilf R
    Cancer Res; 1978 Nov; 38(11 Pt 1):3646-55. PubMed ID: 698924
    [No Abstract]   [Full Text] [Related]  

  • 10. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS; Clair T; Cho-Chung YS
    Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat.
    Ip C; Ip MM
    J Natl Cancer Inst; 1981 Feb; 66(2):291-5. PubMed ID: 6779045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone dependency of rat mammary carcinoma--a comparison of two assay systems.
    Sarkar S; Seshadri R; Shah PN; Kothari LS; Ghosh SN
    Neoplasma; 1979; 26(4):477-82. PubMed ID: 118387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear protein phosphorylation and hormone-dependent mammary tumor regression following dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Cho-Chung YS; Redler BH; Lewallen RP
    Cancer Res; 1978 Oct; 38(10):3405-9. PubMed ID: 210937
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Gibson SL; Hilf R
    Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Gibson SL; Hilf R
    Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estradiol receptors in the plasma membranes of cells in hormone-dependent mammary tumors].
    Morozova TM; Volchkov VE; Merkulova TI; Nagibneva IN
    Dokl Akad Nauk SSSR; 1983; 272(6):1494-7. PubMed ID: 6418499
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
    Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
    J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.